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1. Introduction 
The investigation into the reaction of tissues on organic and inorganic particles is the topic 
of a multitude of medical disciplines. In the area of hygienics, industrial medicine and 
pulmonology for instance, the effects of fine dust particles in the lungs are examined 
(Wottrich et al. 2004). In the field of oncology, now and then the possible influence of nano 
foreign-body particles on carcinogenesis is being investigated (Jacobs et al. 1998). From the 
viewpoint of the immunologist, the different attitudes of cells and variable receptor 
activities during the phagocytosis of foreign bodies are of interest (Sun et al. 2003). 
In the region of surgical disciplines like orthopaedics, trauma surgery or maxillary surgery, 
particle studies that investigate the influence of the abrasion of different prosthetic materials 
on the peri-prosthetic tissue have been undertaken in order to get evidence on their respective 
biocompatibility. In orthopaedics, this question is of importance mainly in the field of the total 
endoprosthetic hip replacement. Hip joint prostheses rank as most frequently performed 
implantations of biomaterials in orthopaedics and are particularly affected with regard to the 
formation of wear debris and loosening because of their exceptional mechanical use. 
2. The development of the artificial hip joint replacement 
At about 1.3 million implantations of biomaterials worldwide per year, the artificial 
replacement of the hip joint counts among the most frequent operations in the frame of 
orthopaedic surgery (Harris et al. 1995). In Europe, 500,000 hip joint prostheses are 
implanted annually. In Germany, there are about 200,000 every year including up to ten 
percent replacement of an already existing prosthesis (Özkir et al. 2007). In the USA, 600,000 
total hip arthroplasties (THA) are implanted yearly at present. Up to the year of 2030 the 
annual requirements of primary THA will probably rise from 209,000 to 572,000, an increase 
by 174%. The future need by patients younger than 65 years will presumably come to 52% of 
the primary THA. The annual hospital expenses for primary THA will rise to 17.4 billion 
US$ up to 2015. According to estimations the number of THA revisions will increase from 
40,800 (year 2005) to 96,700 (2030) in United States. The expected rise of THA revisions will 
be at 137% (Kurtz et al. 2007).  
The idea of an artificial hip joint can be traced back to design drawings made by Gluck at 
the end of the 19th century. The first translation of this idea into action took place by Hey-
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Groves in 1922, who used an implant from ivory as a femur head prosthesis. The first 
metallic total hip arthroplasty – consisting of an acetabulum and a femur head fastened to 
the neck of the femur by a bolt – was implanted by Wiles in 1938. 
Today, the fixation occurs in the femur by an intra-medullary metallic stem. The first 
operation that was performed this way was done by Moore in 1940.  
The results of the hip joint replacement, at first scanty concerning durability and load 
capacity, could be improved in 1959 by the introduction of bone cement (polymethyl 
methacrylate, PMMA) by Sir John Charnley (Herren et al. 1987). 
Today, the most frequently used materials in hip arthroplasty are titanium alloys (e.g. 
titanium-aluminium-vanadium, TiAlV) or cobalt-chromium-compounds, polyethylene (e.g. 
ultra-high-molecular-weight-polyethylene, UHMWPE), and aluminium ceramics (Al2O3). 
2.1 The significance of aluminium ceramics in hip arthroplasty 
Bio-ceramics are an alternative to metal alloys for total hip replacement. Alumina is the most 
widely used oxide ceramic material for orthopaedic implants. Alumina ceramics are 
manufactured from powdered aluminium oxide which is mixed with an organic binder and 
pressed into a mold. The material is then dried to evaporate the water and calcinated to 
burn the organic binder. The quality and purity of the powdered raw material and the 
temperature of calcination determine the microstructure of ceramics (Hannoche et al. 2005).  
Ceramics became of great interest in hip arthroplasty (Manley et al. 2008) as they promised a 
solution to the problem of aseptic loosening. Clinical and experimental studies showed that 
pairings of alumina ceramics in comparison to the widely used polyethylene/metal pairings 
lead to less debris. Wear particles can stimulate osteoclasts around the implant resulting in 
particle-induced osteolysis – the major cause of long time failure in hip arthroplasty 
(Sunfeldt et al. 2006).  
Many authors concluded that the number of revision surgeries of ceramic/ ceramic pairings 
due to aseptic loosening is lower compared to polyethylene/ metal pairings (Clarke et al. 
1994). Until 2001, more than 3 million ceramic prosthetic heads and more than 300,000 
ceramic acetabular cups were successfully implanted worldwide (Thompsen et al. 2002). 
The combination of a ceramic head combined with a polyethylene cup reduces the particle 
wear by half compared to a metal/polyethylene pairing. (Hannoche et al. 2005) The 
combination of a ceramic head and a ceramic cup can further reduce the particle wear by ten 
times (Hannoche et al. 2005). Nowadays, the most widely used combination in total hip 
arthroplasty is that of a ceramic head with a polyethylene cup (Rössler and Rüther 2005). 
The idea to use ceramic materials for hip replacement comes from the French surgeon Pierre 
Boutin. In 1970, he implanted a cemented ceramic cup combined with a ceramic head for the 
first time. In 1974, Peter Griss and Heinz Mittelmeier introduced the regular use of ceramic 
heads and cups in Germany. Meanwhile, most ceramic materials are based on alumina 
(Al2O3) (Hannoche et al. 2005). An advantage of using ceramics in hip joint replacement is 
that laboratory experiments showed ceramics to be bio-inert. The material  does not corrode, 
it is well tolerated by the surrounding tissue and produces significantly less wear than 
current alternative materials of ultra-high molecular weighted polyethylene (UHMWPE) 
and titanium aluminium vanadium TiAlV (Manley et al. 2008, Warashina et al. 2003).  
Ceramics possess advantageous tribological characteristics (Bierbaum et al. 2002). In-vivo 
experiments showed that the ceramic surface forms a lubricating protein-rich film after 
implantation that works as sliding layer (Christel 1992). 
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In the 70ties, so-called monolithic or bloc cups entirely made of ceramics were used at the 
beginning. They demonstrated good bio-inert characteristics and a high corrosion resistance 
but a poor osteo-integration. A fibrous tissue was frequently found between implant and 
bone leading to migration and loosening of the prosthesis due to change of position of the 
components and resulting in increased abrasion (Willmann1998). Therefore, the results in 
the early era of ceramic hip implants have been poor. Many studies from this period 
reported revision surgeries in 30 % of the patients after 5 years compared to significantly 
better results of metal / polyethylene combinations (Mahoney et al. 1990). Furthermore, the 
initial poor performance of ceramic hip joints is attributed to the mechanical characteristics 
of ceramics. The brittle, inelastic material can hardly compensate forces by deformation. 
Therefore, fractures of ceramics, mostly found in the femoral part, were more frequent than 
in prostheses out of polyethylene or titanium alloys (Manley et al. 2008). Ceramic implants 
demand an experienced surgeon as the positioning of the implant e.g. inclination, ante-
version, offset and neck length, is of great importance for the long-term results. The correct 
positioning of cup and stem reduces asymmetric strain on the implant, avoids an 
impingement and reduces the material abrasion and fracture.  Hamadouche et al. published 
excellent long-term results in correctly positioned ceramic prosthesis (Hamadouche et al 
2002). Savarino et al. recently published a study showing that trauma, infection, mechanical 
instability and incorrect positioning mostly lead to implant failure of alumina ceramic on 
alumina ceramic hip prosthesis. They pointed out that particle-induced osteolysis was no 
longer the number one reason of long-term failure (Savarino et al. 2009). 
Another reason for the improvement of durability of alumina ceramics was a constant 
development of the material. First generation alumina ceramic materials consisted of large 
(7.2 micron particle size), less strong (400 MPa) and less dense (3, 94 g / cm ³) crystals and 
showed impurities of up to 5 percent by volume. Currently, third generation alumina 
ceramics consist of crystals with a much finer grain size (1.8 microns). They have a higher 
density (3.98 g / cm ³), higher stability (580 MPa) and impurities of less than 0.5 percent by 
volume. (Hannoche et al. 2005) 
In addition to the improving surgical technique and the higher quality of the raw material, 
the geometric shape of the femoral head and acetabular cup were optimized leading to a 
significant increase in the longevity of ceramic prosthesis (Thompsen et al. 2002).     
Clinical outcome studies confirmed that a total hip prosthesis made of alumina ceramic has 
good durability and low particle wear. Rousseau et al. (2004) reported of an average 
survival rate of 62.8% after 11 years of cemented alumina ceramic on alumina ceramic hip 
replacements. Lusty et al. (2007) found a survival rate of 99% after a mean of 7 years in 
cementless alumina-on-alumina ceramic hip replacements. 
2.2 The aseptic loosening of the hip prosthesis 
While in the early times of hip arthroplasty secondary complications were most frequently 
caused by material fatigue, inaccurate implantation techniques, and infections, today – 
following improvements in the methods of operation, sterilisation, and material 
development – the aseptic loosening of the prosthesis is the most common reason for 
orthopaedic revision operations (Sundfeldt et al. 2006). 
During the aseptic loosening of a prosthesis, there is a progressive periprosthetic osteolysis 
in the course of time leading to a growing instability and increasing wear triggered by the 
advancing mobility of the prosthesis. In the long term, this results in the loosening and 
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dislocation of the prosthesis. A reason for the limited durability of the endoprosthesis is 
therefore caused by the composite of the implant and the surrounding bone tissue. In 
addition, the aspect of material wear plays a role. For the patient the loosening of the 
prosthesis appears in the form of pain following exercise or on movement (Rössler and 
Rüther 2005). As things develop revision operations are often inevitable. They weigh heavily 
upon the patients and are susceptible to risks because of peri- and postoperative 
complications (e.g. embolism or infections). Moreover, the secondary implant requires a 
greater intramedullary volume at each replacement of a hip prosthesis. Thus, the durability 
of the replacement prosthesis is significantly reduced in comparison to the first implant and 
the number of possible replacements is limited (Callaghan et al. 1985, Hanssen et al. 1988).  
The real cause for the formation of periprosthetic osteolysis followed by aseptic loosening is 
still disputed. There is a multitude of theories: 
2.2.1 Bone resorption induced by wear debris 
Many authors in the contemporary technical literature assume that the wear debris 
generated by the abrasion of the prosthesis is phagocyted by cells of the surrounding tissue, 
thereafter activating these cells and giving rise to an aseptic reaction by release of different 
messenger substances (e.g. cytokines like interleukins or TNF-α), eventually causing the 
osteolysis of the surrounding bone. A significant role in this connection is assigned to the 
macrophages activating already present osteoclasts in the described manner or stimulating 
precursor cells to become osteoclasts or even further differentiating themselves into 
osteoclasts (Fujikawa et al. 2005). Furthermore, studies are mentioned in literature stating 
that other tissue cells, e.g. osteoblasts, are also able to phagocyte wear particles and to react 
to them (Lohmann et al. 2000). The cellular response caused by the wear debris and the 
connected bone resorption are dependent on different physical characteristics such as the 
material the particles are made from as well as their size, amount and morphology. 
Schmalzried et al. (1992) consider that the aseptic loosening of the femur shaft  is mainly due 
to mechanical reasons, while merely the loosening of the acetabulum, mostly consisting of 
polyethylene, is caused in the manner described above by bone resorption induced by wear 
debris. 
2.2.2 The hydrostatic pressure 
Schmalzried et al. (1992) and Aspenberg et al. (1998) regard an increased intracapsular 
pressure as an important factor in the origin of aseptic osteolysis. According to their theory 
the intra-articular cartilage in normal joints prevents the contact between bone and synovial 
fluid. As part of a disease or a trauma, a damage of the cartilage and consequently a loss of 
its osteoprotective properties is however possible. There will be an inflammation of the joint 
with the development of more intra-articular liquid. The result is an increased intracapsular 
pressure which reduces the blood circulation to the bone and leads to the ischaemic death of 
osteocytes consequentially leading to increased bone resorption. This theory is supported by 
studies of Robertsson et al. (1997), who discovered an increased intracapsular pressure in 18 
implanted hip joints shortly before a revision operation because of aseptic loosening, 
compared to 34 clinically and radiologically stable hip joint implants. In addition, 
Aspenberg and van der Vis (1998) were able to show in a rabbit experiment that an 
oscillating intracapsular liquid pressure results in osteolysis and the death of osteocytes. 
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2.2.3 Endotoxic contamination of implants and particles 
Hitchins and Merritt (1999) consider bacterial cell components attached to the hip joint 
implants (lipopolysaccharides, endotoxins) to be responsible for osteolysis. This theory is 
also supported by Akisue et al. (2002), who incubated macrophage-like THP-1 cells with 
titanium particles and endotoxins and observed almost no effect of endotoxin-free titanium 
particles on the expression of cytokines in their experiment. 
2.2.4 Genetic predisposition 
Matthews et al. (2000) pursued observations where certain patients showed no failure of 
their implant in spite of massive polyethylene abrasion, while in other patients with only 
small wear amount the implants failed with a distinct osteolysis. In a cell culture study, 
where macrophages from three different donors had been incubated by endotoxin-free 
polyethylene particles, they discovered a high variability of the macrophage cytokine 
expression induced by particle contact dependent on the donors. A similar discovery was 
made by Hatton et al. (2003), who incubated peripheral blood monocytes from six different 
donors with particles of aluminium ceramics and observed significant differences between 
the donor cells in the release of TNF-α. Genetic investigations on the correlation between 
genetic nucleotide polymorphisms and aseptic hip prosthesis loosening are currently under 
way (Wedemeyer et al. 2009, Bachmann et al. 2008). 
2.3 In vivo and in vitro studies on wear particles 
Until now, a lot of studies to clarify the morphological characteristics of wear particles have 
been carried out. It turned out that the peculiarity of the wear debris and hence the amount 
of wear particles in the periprosthetic tissue was dependent on the used material of the 
prosthesis. 
Different methods have been used for the quantitative investigation of wear debris. These 
include calculations in the frame of radiographic studies and recently also calculation 
models with the help of prosthetic simulators. The latter have also been used to determine 
morphology and amount of the wear particles arising over time. At the same time there 
were clinical studies analysing the intra-operatively recovered particles afterwards, e.g. 
during a revision operation or the replacement of a loosened prosthesis. 
The above mentioned investigation methods showed the highest rate of wear debris  (6 to 
140 mm³ per year) for polyethylene in comparison to other materials (Livermore et al. 1990). 
On the other hand, for prostheses made from ceramics comparatively little wear debris is 
described. Lusty et al. (2007) mentioned a mean abrasion of 0.2 mm³ per year. You et al.  
(2005) were not able to ascertain any wear debris in their radiological study, whereby in this 
case the assessment took place five years after the implantation of the prosthesis. 
Concerning the size of the particles found in vivo, there is a dependence on the used 
prosthesis material, too, but like in the abrasion rate there are differences between authors 
also concerning the particles’ size. Maloney et al. (1995) generally observed a mean particle 
size of just below 1µm for non-cemented polyethylene and metallic prostheses and an 
absolute number of 1.7 billion particles per gram tissue. Studies by Lee et al. (1992) on tissue 
recovered from cemented prostheses during revision operations yielded a similar particle 
size for metallic particles (TiAlV, CoCr, steel) between 0.3 and 1.8 µm and for polyethylene 
particles a magnitude between 2 and 13 µm.  
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During electron microscopic analysis of wear particles from Mittelmeier-prostheses 
(ceramics on ceramics) Yoon et al. (1998) found sizes between 0.13 and 7.20 µm (mean 0.7 
µm). Hatton et al. (2003) on the other hand identified particles from ceramics in two 
magnitudes by a laser-based micro-dissection method (likewise on failing Mittelmeier-
prostheses), one group with a mean diameter of 0.503 µm, while the other group showed a 
diameter on the nanometre scale (24 ±  19 nm). 
The signalling pathways that have been investigated until now in cell-particle co-culture 
systems mainly contain cytokines (interleukins, TNF-α), prostaglandins and recently the 
RANK(L)/OPG-system, too, which so far, however, has only been tested on metallic and 
polyethylene particles (Baumann et al. 2004) and not as yet on aluminium ceramics. On this 
occasion, an increased expression resp. release of the corresponding messenger substances 
was connected with growing particle concentration and also in these cell culture studies 
polyethylene and different metallic particles induced a more distinct cellular response than 
particles from aluminium ceramics (Sterner et al. 2004). Concerning the influence of the 
particle size, however, different effects have been observed. For instance Sterner et al. (2004) 
described a proportional correlation between the size of aluminium ceramics particles and 
the release of TNF-α in macrophage-like cells, while Yagil-Kelmer et al. (2004) as the only 
authors so far concluded from their studies that smaller ceramics particles in single 
individuals might have a more significant biological answer than particles of the same 
material but with greater diameter. 
Catelas et al. (1999) investigated the impact of aluminium ceramics particles on cell death 
mechanisms (apoptosis versus necrosis) in macrophage cultures and reported on a volume 
effect where cells showed apoptotic changes dependent from a combination of size and 
concentration of the deployed particles. 
In a co-culture with a murine macrophage cell line, Petit et al. (2006) examined the influence 
of bisphosphonates on the release of TNF-α and the induction of apoptosis. It turned out 
that only the TNF-α-release induced by polyethylene (UHMWPE) particles could be 
inhibited, not the one induced by particles from aluminium ceramics and that 
bisphosphonates lead to an induction of apoptosis in the cells. 
2.4 Monocytes and macrophages 
Monocytes are mononuclear phagocytes circulating in the blood. They represent precursors 
of macrophages. In particular at inflammatory processes in the neighbouring tissue, 
monocytes are caused by chemotaxis to enter the tissue concerned where they differentiate 
to macrophages under the prevalent humoral stimuli and are able to survive there for a 
period from a few days up to several months. During this time the macrophages are 
performing most diverse functions: By secretion of messenger substances (cytokines, 
leukotrienes, prostaglandins, proteases, complement factors, etc.) for instance, these cells 
initiate inflammatory reactions as well as conversion and repair processes in the 
surrounding tissue. They phagocytose very different organic and inorganic materials, both 
foreign-bodies and own tissue, whereby the phagocytosis is being facilitated by previous 
opsonization of the materials being phagocyted by antibodies or complement proteins. The 
macrophages participate in immunological processes (immune defence) by antigen 
presentation at lymphocytes (Schiebler et al. 2002). 
Within the framework of the particle-induced periprosthetic osteolysis the macrophages 
have a special significance in double regard: on the one hand, especially these cells react to 
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the particles by introduction of a pro-inflammatory signalling cascade, which eventually 
leads to an increased activation and recruitment of osteoclasts. On the other hand, the wear 
debris is able to inhibit the effect of osteoprotective mechanisms, e.g. the release of the 
osteoprotective interferon-gamma, whereby a differentiation of macrophages into 
osteoclasts is being facilitated (Purdue et al. 2006). 
2.4.1 The THP-1 cell line and cell-particle co-culture systems 
Tsuchiya et al. (1982) established this cell line and were able to verify their numerous 
monocytic properties, especially the potentiality for phagocytosis of foreign-body particles. 
Furthermore, the authors demonstrated that a treatment of this cell line by the phorbol ester 
phorbol-12-myristate-13-acetate (PMA), also called 12-O-tetradecanoylphorbol-13-acetate 
(TPA), results in a further differentiation along the monocytic development line up to 
macrophage-like cells (Tsuchiya et al. 1982). This happens via a signalling pathway 
mediated by protein kinase C, where PMA functions as an analogue for diacylglycerole, the 
physiological activator of protein kinase C. Schwende et al. (1996) observed a significant 
amplification of characteristics typical for macrophages if THP-1 cells were stimulated by 
PMA in a concentration of 10 nmol over 72 hours: This includes an increased expression of 
the surface proteins CD14 and CD11b typical for monocytes and especially macrophages 
and an intensified potential for the secretion of oxygen radicals. Additionally, they 
concluded that the PMA treatment induces an increase of TNF-α-cytokine release from the 
cells, inducible by lipopolysaccharides. Further observations showed cells stimulated by 
PMA are able to phagocytose about ten times more latex particles than unstimulated cells, 
and the morphological development to macrophages reached by the PMA treatment is quasi 
accompanied by a termination of the very high cell division rate known from the untreated 
cells. Beside different humane and murine cell lines, fresh peripheral blood monocytes 
(PMBC) extracted from donors have often been used (Yagil-Kelmer et al. 2004). There are 
only occasional reports about PMA stimulated THP-1 cells used for the analysis of osteolysis 
inducing properties of biomaterials. More often particle studies have been carried out with 
THP-1 cells using other substances than PMA for the stimulation to macrophage-like cells. A 
research group from Würzburg, Germany, used THP-1 cells which had been pre-treated by 
a granulocyte macrophage colony-stimulating-factor (GM-CSF) and vitamin D3 (Baumann et 
al. 2004). 
2.5 TNF-α und das RANK(L)/OPG- system 
2.5.1 Osteoprotegerin (OPG) 
The identification and characterisation of the RANK(L)/OPG system began in 1997 by   
discovery of Osteoprotegerin (OPG). It just happened by accident at the AMGEN company 
where cDNA from rat intestinal tissue had been characterised in a study. The researchers 
were looking for TNF receptor-like molecules, hoping for their therapeutic benefit. Certain 
transgenic mice which overexpressed the gene for OPG attracted attention because of a 
distinct osteopetrosis (Simonet et al. 1997). It was discovered that this was due to a decrease 
of the number of osteoclasts in the mouse skeleton and it was concluded that OPG plays a 
key role in the regulation of the osteoclastogenesis.  
Apart from that, a Japanese research group discovered osteoprotegerin almost at the same 
time. Here, they were searching specifically for an undiscovered factor produced by 
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osteoblasts and stromal cells which they awarded regulatory features concerning the 
osteoclastogenesis and hence the bone resorption (Yasuda et al. 1998). 
In detailed analyses of OPG, it turned out that OPG is a peptide comprising 380 amino 
acids. OPG is secreted as a 401 amino acids-long peptide where a propeptide of 21 amino 
acids is being split off (Simonet et al. 1997, Yasuda et al. 1997). It represents the only protein 
of the TNF receptor super-family which does not possess transmembrane and cytoplasmatic 
domains and which is secreted as a soluble protein. Using OPG-knockout mice, it was found 
that OPG apparently plays an important role in other organ systems, too. This is because a 
suppression of the OPG in the mice not only culminated in strong osteoporosis but also in 
changes in the vascular system, e.g. calcifications of the large arteries, proliferations of the 
intima and media and  aortic dissections. Meanwhile, it is known that OPG-mRNA is being 
expressed in almost all organs (Simonet et al.1997, Yasuda et al. 1997). 
2.5.2 Receptor Activator of Nuclear Factor kappa B Ligand (RANKL) 
Soon after the discovery of OPG it became apparent that a protein already known 
concerning its ability to stimulate dendritic cells, the RANKL, works as a ligand of OPG. For 
this reason it is also called osteoprotegerin ligand (OPGL). In the presence of a low M-CSF 
level, RANKL is necessary and sufficient for the complete differentiation of osteoclast 
precursor cells to mature osteoclasts (Lacey et al. 1998).  
Again during knockout mice experiments it was demonstrated that the elimination of the 
RANKL gene entailed a strong osteopetrosis and a total missing of osteoclasts (Kong et al. 
1999). RANKL has been identified as a peptide with a length of 317 amino acids. It exists in a 
membrane bound and also in a soluble mode. The latter emerges through separation of a 
peptide part at position 140 or 145 (Lacey et Al: 1998). 
2.5.3 Receptor Activator of Nuclear Factor kappa B (RANK) 
By the discovery of RANKL as a potential ligand for OPG, it was concluded that also 
RANK, an already known receptor for RANKL, should play a crucial role in 
osteoclastogenesis and bone resorption.  
The absence of RANK in knockout mice induces a distinct osteopetrosis, attributable to the 
complete missing of osteoclasts (Kong et al. 1999). Detailed analyses of RANK showed it to 
be a peptide with a length of 616 amino acids. It is composed of a signal peptide with 28 
amino acids, an N-terminal extracellular domain, a short transmembrane domain of 21 
amino acids and a large C-terminal cytoplasmatic domain. It is mainly expressed on 
monocytic cells and macrophages and also on pre-osteoclasts, B- and T-cells, dendritic cells 
and fibroblasts (Anderson et al. 1997).  
The signal transduction running via RANKL and RANK eventually ends with the regulation 
of the nuclear transcription factor NF-kB. In its inactive form, NF-kB is bound to different 
inhibitor proteins in the cytoplasm. In the case of activation, these are degrading and the NF-
kB molecule is able to translocate to the nucleus where it controls the transcription of a 
multitude of genes and, besides the osteoclastogenesis, it also regulates significantly apoptotic, 
inflammatory and autoimmune modulatory processes (Holt et al. 2007).  
2.5.4 Tumor Necrosis Factor alpha (TNF-α) 
The cytokine TNF-α is being secreted mainly by activated macrophages and owns a multitude 
of functions. Through its capability to stimulate osteoclasts, it is a potent mediator of bone 
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resorption (König et al. 1988) and it also plays an important role in the frame of inflammatory 
diseases and post-menopausal osteoporosis (Komine et al. 2001). The role of TNF-α in bone 
resorption has been studied by means of a knockout survey: Merkel et al. (1999) observed a 
hardly detectable bone resorption after elimination of the TNF-α receptor in mice following 
subperiostal implantation of bone cement particles. Furthermore, it could be noticed that TNF-
α not only shows a synergistic effect to RANKL, but it also initiates a signal cascade via its 
receptor leading again to the activation of the transcription factor NF-kB.  
The stimulation of osteoclasts, however, is not due to TNF-α alone. The presence of M-CSF 
is needed, too. Both factors together ensure a differentiation of haematopoietic progenitors 
to dendritic cells and hence an enlargement of the pool of pre-osteoclastic cells (Udagawa et 
al. 1990). 
2.5.5 The RANK(L)/OPG system and TNF-α in the particle-induced osteolysis 
Because of the affiliation of RANK and OPG to the TNF receptor superfamily, the following 
synonyms exist in the current nomenclature: RANK is also called Tumor Necrosis Factor 
Receptor Superfamily, member 11A. For RANKL there is the synonym Tumor Necrosis 
Factor Receptor Superfamily, member 11 and OPG is also considered as Tumor Necrosis 
Factor Receptor Superfamily, member 11B.  
Like a multitude of other pro-inflammatory proteins (e.g. interleukin-1), TNF-α is in the 
position to stimulate the osteoclastogenesis via an activation of NF-kB. However, these 
cytokines do not belong to the final step of the signal cascade. This is rather composed by 
the RANK(L)/OPG system (Holt et al. 2007).  
Because of the observations made so far, RANK must be the only receptor for RANKL on 
the cell surface of osteoclast precursors. OPG, which may be bound by RANKL, but with an 
opposite effect in bone metabolism, hence turned out as a soluble “decoy receptor” catching 
RANKL in the intercellular space without bone resorption resulting from this binding. 
The relation of RANK and RANKL on one hand and OPG on the other is decisive for the 
way (construction resp. resorption of bone) and the extent of bone metabolism because of 
the above mentioned observations. The relevance of this relation has been confirmed in the 
area of the particle-induced aseptic osteolysis. During analyses of periprosthetic tissue 
surrounding loosened hip joint prostheses, a strong increase of RANK and RANKL 
expression could be found and in comparison a low expression of OPG (Mandelin et al. 
2003). A further conclusion that could be drawn from this study was the fact that an 
imbalance in favour of RANKL and to the detriment of OPG induces the enhancement of 
osteoclastogenesis and hence loosening of the prosthesis.  
2.6 THP cells and ceramic particles 
We recently performed a study to illuminate the effect of alumina ceramic particles with 
different diameters and concentrations on the mRNA expression of certain key regulators in 
particle-induced aseptic osteolysis (RANK, RANKL, OPG, and TNF-α) in THP-1 
macrophage-like cells (Bylski et al. 2009). Titanium particles were used as a positive control. 
RNA was analyzed by quantitative RT-PCR. Our results demonstrate that alumina ceramic 
particles, regardless of particle size, caused only slight up-regulations of RANK, TNF-α, and 
OPG mRNA, whose levels were significantly lower in comparison to those of titanium 
particles (p < 0.05). The continuous increasing tendency to time-dependent and particle-
dependent mRNA-expression of all the parameters stimulated by titanium particles was not 
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found after stimulation with ceramic materials. Even after the concentration of ceramic 
particles was increased, only a mild up-regulation of mRNA-expression was found. 
Furthermore, we observed that the bio-inert characteristics of ceramic particles did not 
change much in diameters ranging from 0.5 to 1.5 µm. At most of the measuring time points, 
there was no significant difference between the reactions of the large and small particles in 
this range. Our results support the theory about the relative bio-inert characteristics of 
alumina ceramic particles. 
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e) 
 
 
f) 
Fig. 1. Light microscopic photographs of PMA-stimulated THP-1 cells after 
immunohistochemical staining by CD68 antibodies (a-c) resp. at co-incubation with 
particles (d-f): (a): 3 million THP-1 cells treated by 50 nmol PMA for 72 h, magnification 4x.  
(b): 1 million cells treated by 50 nmol PMA for 48 h, magnification 10x.  (c): 5 million cells 
treated by 50 nmol for 72 h, magnification 10x. Cell aggregations are recognizable because of 
the high density.  (d) + (e): THP-1 cells treated by PMA for 72 h phagocytosing titanium 
particles (for better overview at the rate of 1:10). After about 1 h already, a particle 
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accumulation in the cytoplasmic area could be recognized by light microscope. Besides the 
clearly visible large titanium particles (deep black), the smaller particles appear more 
transparent. Magnification 100x.  (f): Ceramic particles of the kind CT1200SG in the 
cytoplasm of THP-1 cells treated in the same way. In comparison to the titanium particles, 
the smaller size of the ceramic particles is distinct. Under the light microscope, they are only 
distinguishable from the roundish intracellular vacuoles by their more oval shape.  
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Fig. 2. Alteration of expression of RANK, TNF-α, and OPG caused by titanium and ceramic 
particles after an incubation time of 6 hours. Like before, the normalization took place by aid 
of the housekeeping-genes ß-actin and HPRT (here called HKG). A significant increase in 
expression could only be verified for TNF-α, which rose significantly in both titanium 
particle concentrations (group A and B, each p<0.05), while ceramic particles did not create 
a significant alteration of expression in any of the three genes. The group with smaller 
ceramic particles (group E) rather seemed to produce a decent but not significant 
suppression of RANK- and OPG-mRNA. 
2.7 Possibilities and sense of prevention and intervention on particle-induced 
osteolysis 
Currently, there exist several possibilities to prevent or to retard aseptic hip joint loosening 
whereas the different measures can start at different stages of anamnesis of patients with 
artificial hip joints. 
In keeping with the philosophy of prevention, it could be targeted to avoid the necessity of 
hip implantation, for example by the reduction of adiposity as one of the most common 
causes for joint arthrosis, its early detection and conservative treatment. 
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If hip implantation is inevitable, its durability also depends on the surgeons experience and 
surgical technique. To avoid material abrasion or even fracture of the prosthesis, especially 
in case of ceramic prosthesis – described in chapter 2.1 – the exact positioning of the 
prosthesis components is particularly important. 
To improve durability of prostheses, some decisive technical optimization were carried out 
referring to material properties as well as biocompatibility and durability. In the case of 
polyethylene, a smaller material abrasion has been reached by increasing the number of 
intermolecular binding (highly cross-linked UHMWPE), by high dosage gamma irradiation 
or by application of vitamin E for capturing the originated free radicals (Oral et al. 2007). 
After the already undertaken further development of aluminium ceramics – e.g. by increasing 
purity level, strength and density – the research on this material continues to improve its 
tribological properties and especially its capacity (Masson et al. 2009). Using non-oxide 
ceramics, for instance silicon nitride or silicon carbide, Cappi et al. (2010) are aiming at 
applying ceramics for thin-walled implants (e.g. for resurfacing hip prostheses) which had not 
been possible previously because of the low mechanical strength of oxide ceramics. 
2.8 Possible future problems of ceramics/ceramics sliding contact surfaces 
The growing interest of orthopaedic surgeons in modern sliding contact surfaces like 
ceramics/ceramics is reflected by the more frequent clinical application  to reduce wear 
debris and consequentially osteolysis in the young and active patient. Their wide range of 
use over the past decade, however, has led to complications, too, one being the developing 
of movement-related noises in hip-TEP patients. Most recent publications show that noises 
can occur in all sliding contact surfaces (Pokorny et al. 2010). 
3. Conclusion 
As ceramic bearing designs continue to improve with modified materials and 
manufacturing techniques, use will increase, especially in young and active patients and in 
concern to an earlier indication for total joint replacement and considering an eldery 
population. Clinical results for ceramic joint replacement , especially in young and active 
patients, show lower wear rates and a significant reduction of osteolysis. Furthermore our 
results support the thesis of bioinertness of ceramic components. New ceramic components 
are still under development, and the long-term results have to be evaluated over the next 
decades. Not every modern concept will likely stand the test of time, but some will be 
beneficial for patients undergoing total hip arthroplasty in the future. 
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